Report - 202514Orig1s000 - Food and Drug Administration · 2011. 1. 7. · pg/mL, or 0.5 nM). Following 8-day q.d. admi nistration of tafluprost 0.0015% Preservative-free (PF) ophthalmic solution,

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form